Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JMKX000623 for diabetic peripheral neuropathic pain
CTR20240670Phase 2Completed
- Sponsor
- Jeyou Pharmaceutical
- Start
- Mar 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of JMKX000623 in diabetic polyneuropathy (DPN) (2 arms), sponsored by Jeyou Pharmaceutical. Primary endpoint: Change from baseline in Average Daily Pain Score (ADPS) at Week 12. Started Mar 2024; status: completed.
02
Drugs
JMKX000623
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on CTR20240670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240670.